Nandrolone Decanoate
Deca · Deca-Durabolin
Half-life
8 days
Time to Peak
4 days
Steady State
~40 days
Bioavailability
100%
Dose Range
50–600 mg
Frequency
Weekly
Overview
Long-acting nandrolone ester. FDA-approved for anemia of chronic kidney disease. One of the most widely studied AAS compounds. Approximately 6x more anabolic than testosterone with lower androgenic activity. Suppresses endogenous testosterone very strongly — should always be co-administered with exogenous testosterone. Very long detection time (12-18 months) due to fat-soluble metabolite 19-norandrosterone. Harm reduction: Monitor hematocrit, prolactin, and progesterone. Consider cabergoline or P5P for prolactin management if needed.
Mechanism of Action
19-nortestosterone derivative. Binds androgen receptor with high affinity. Lower 5-alpha reduction to DHN (weaker metabolite) compared to testosterone's conversion to DHT. Progestogenic activity contributes to some side effects.
Dosing Information
| Route | Dose Range | Half-life | Tmax | Frequency |
|---|---|---|---|---|
| Intramuscular (IM) | 50–600 mg | 8 days | 4 days | Weekly, Every 2 weeks |
Storage & Handling
Room temperature — Store at 20-25C. Protect from light. Oil-based solution.
Used in Regimens
1 regimenData Sources
- Peer-reviewed Minto CF et al. Pharmacokinetics and pharmacodynamics of nandrolone esters in oil vehicle
- FDA Label Deca-Durabolin (nandrolone decanoate) FDA Prescribing Information
Related Tools
Track Nandrolone Decanoate with Doseline
Reminders, medication level charts, injection site rotation, and protocol tracking — all free, all private.
Join the waitlistDoseline provides informational tools only. It is not a medical device and does not provide medical advice. Always consult a qualified healthcare provider.